IL19 and breast cancer: IL-19 expression levels have proven to predict worse disease-specific survival and metastasis-free survival, and it is believed that IL-19 acts primarily as a local mediator in the microenvironment that affects breast cancer cells and that acts in an autocrine manner in breast cancer [41].